Target intelligence / Profile preview

Rh D antigen (often referred to as "D antigen of the Rh blood group system") is the official full name for this molecule, encoded by the RHD gene (RhD)

Target: RhD
Molecular classification: Blood group antigen, Transmembrane protein, Integral membrane protein, Erythrocyte surface protein, Related to ammonia transporter family, but specific transport function is unproven for RhD

Overview

Rh D antigen is a transmembrane protein expressed on erythrocytes, encoded by the RHD gene. It is responsible for the D antigen of the Rh blood group—one of the most clinically important blood group antigens due to its role in hemolytic disease of the newborn and transfusion reactions. RhD forms part of a complex with RhAG and RhCE proteins in the red cell membrane, maintaining membrane integrity and possibly participating in transport mechanisms, though no definitive physiological function is established for RhD itself. The protein is a major immunogen for humans; anti-D antibody formation occurs readily in RhD-negative individuals exposed via transfusion or pregnancy to RhD-positive erythrocytes. Partial and weak D variants arise from gene conversions or point mutations, influencing clinical management in transfusion and obstetric medicine.

Other names: D antigenRhesus factorRh factorRh polypeptide 1 (RhPI)Cluster of differentiation 240D (CD240D)

Mechanism of action

Anti-D immunoglobulin binds Rh D antigen on fetal/neonatal/blood donor erythrocytes, prevents maternal sensitization (formation of anti-D antibodies), and blocks immune-mediated hemolysis

Biological functions

Determines Rh blood group status (D-positive or D-negative)Integral to erythrocyte membrane structure and stabilityPutative function in membrane transport (CO₂ or NH₃)Immune recognition: triggers alloimmunization in Rh-negative individuals exposed to Rh-positive blood

Disease associations

Hemolytic disease of the newborn (HDN) / erythroblastosis fetalisAutoimmune hemolytic anemia (rarely)Transfusion reactionsPerinatal and transfusion medicine relevance

Safety considerations

Immunogenicity: Rh D antigen is highly immunogenic; exposure can provoke strong antibody response in Rh-negative individualsHemolytic disease risk in newborns if Rh-negative mother is sensitizedTransfusion incompatibility riskRare: Partial D and weak D variants can complicate typing and management

Interacting drugs

Anti-D immunoglobulin (Rho(D) immune globulin, RhIg)

Biomarkers

Presence/absence of RhD antigen used for patient and donor selection (Rh typing)Detection of anti-D antibodies in maternal blood for risk stratification in pregnancyRHD genotype by PCR in prenatal risk assessment

Beyond the preview

Go deeper on Rh D antigen (often referred to as "D antigen of the Rh blood group system") is the official full name for this molecule, encoded by the RHD gene (RhD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rh D antigen (often referred to as "D antigen of the Rh blood group system") is the official full name for this molecule, encoded by the RHD gene (RhD).

Explore the full profile